Premarket Mover: Global Blood Therapeutics Inc (GBT) Up 2.44%

Monday, August 08, 2022 08:41 AM | InvestorsObserver Analysts

Mentioned in this article

Premarket Mover: Global Blood Therapeutics Inc (GBT) Up 2.44%

Global Blood Therapeutics Inc (GBT) has risen Monday morning, with the stock adding 2.44% in pre-market trading to 65.4. GBT's short-term technical score of 100 indicates that the stock has traded more bullishly over the last month than 100% of stocks on the market. In the Biotechnology industry, which ranks 107 out of 146 industries, the stock ranks higher than 100% of stocks. Global Blood Therapeutics Inc has risen 83.19% over the past month, closing at $33.71 on July 11. During this period of time, the stock fell as low as $32.40 and as high as $73.02. GBT has an average analyst recommendation of Strong Buy. The company has an average price target of $59.80.

GBT has an Overall Score of 67. Find out what this means to you and get the rest of the rankings on GBT!

See Full GBT Report

Global Blood Therapeutics Inc has a Long-Term Technical rank of 100. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 0% of the market scoring higher. In the Biotechnology industry which is number 71 by this metric, GBT ranks better than 71% of stocks.

Important Dates for Investors in GBT:

-Global Blood Therapeutics Inc is set to release earnings on 11/6/2022. Over the last 12 months, the company has reported EPS of $-4.87. -We do not have a set dividend date for Global Blood Therapeutics Inc at this time. Click Here To Get The Full Report on Global Blood Therapeutics Inc (GBT)